|
|
In this Cleveland Clinic Heart, Vascular & Thoracic Institute Grand Rounds, Dr. Milind Desai provides an overview of hypertrophic cardiomyopathy, advances in diagnostic evaluation and…
|
|
|
Presented at ACC as a Late-Breaking Clinical Trial, VALOR-HCM explores Mavacamten as an alternative to surgical septal myectomy or alcohol ablation in patients with severely symptomatic obstructive…
|
|
|
Aortic dissection care requires a team approach. Aortic specialists Drs. Cameron, Desai and Lyden discuss how acute aortic dissection patients are triaged and transferred to Cleveland Clinic; use of…
|
|
|
Cleveland Clinic cardiologist Dr. Milind Desai discusses a a paper published in JACC Imaging studying 865 patients who underwent aortic valve surgery with severe aortic regurgitation. Baseline…
|
|
|
Dr. Lars Svensson, Chairman of the Sydell and Arnold Miller Heart and Vascular Institute discusses a recently published paper with Dr. Milind Desai, Medical Director of the Aorta Center, looking at a…
|
|
|
Cleveland Clinic cardiologist Dr. Milind Desai discusses a recently published paper looking at 98 patients with radiation associated severe aortic stenosis who underwent transcatheter aortic valve…
|
|
|
Steven Nissen, MD, Chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic discusses hypertrophic cardiomyopathy (HCM) with experts: cardiologist Milind…
|
|
|
(the CRISP CT study) Dr. Milind Desai describes the findings of a post-hoc analysis of outcome data gathered prospectively from two independent cohorts of consecutive patients undergoing coronary CTA…
|
|
|
Dr. Desai describes the findings of over 1800 patients obstructive HCM in which they reviewed the 5-year primary event rate across the 3 ESC SCD risk categories. The results of this paper shows that…
|
|
|
Dr. Milind Desai discusses the findings of his recently published paper highlighting importance of vegetation size in patients with infective endocarditis and impact on embolic risk. Understanding…
|